Sen. Ron Wyden, D-Ore., left, and Sen. Chuck Grassley, R-Iowa, right, chairman of the Senate Finance Committee, asked drug company CEOs some tough questions about drug prices on Tuesday during a hearing before the Senate Finance Committee. Pablo Martinez Monsivais/AP hide caption
Sen. Estes Kefauver, D-Tenn., (left) and Sen. Everett Dirksen, R-Ill., (second from left) clashed at the reopening of a Senate drug investigation in 1960 over whether witnesses could be forced to reveal business secrets while testifying. Bettmann Archive/Getty Images hide caption
CVS plans to transform some of its stores into "health hubs," retail locations revamped to include more health care services and products. One of the first is in Spring, Texas, a suburb of Houston. Alison Kodjak/NPR hide caption
Families that lost loved ones to the opioid crisis protested outside Suffolk Superior Court in Boston as lawyers for Purdue Pharma entered the courthouse for a status update in the Massachusetts attorney general's suit against the company on Jan. 25. Suzanne Kreiter/Boston Globe via Getty Images hide caption
Anthem Blue Cross of California, one of the state's largest health insurers, is battling Sutter Health over how much it should pay the company's 24 hospitals and 5,000 doctors in Northern California to care for tens of thousands of patients. David McNew/Getty Images hide caption
Juul Labs, the maker of e-cigarettes popular with young, has come under fire from health officials. Since the spring of 2018 the company has been lobbying the federal government. Gabby Jones/Getty Images hide caption
A filing by Massachusetts Attorney General Maura Healey detailed the Sackler family's role in Purdue Pharma's marketing of OxyContin. Toby Talbot/AP hide caption
While some new drugs entering the market are driving up prices for consumers, drug companies are also hiking prices on older drugs. Sigrid Olsson/PhotoAlto/Getty Images hide caption
Even for conventional medical treatments that are covered under most health insurance policies, the large copays and high deductibles have left many Americans with big bills, says a health economist, who sees the rise in medical fundraisers as worrisome. Roy Scott/Ikon Images/Getty Images hide caption
Selling short-term health plan is lucrative for brokers and insurers. skynesher/Getty Images hide caption
Susie Christoff tried several drugs to cope with her painful psoriatic arthritis before finding Cosentyx worked the best. The problem was the cost. Chris Bartlett/for Kaiser Health News hide caption
The "Medicaid Drug Decisions Transparency Act" would require pharmaceutical companies to disclose their payments to pharmacists and others who serve on state Medicaid drug boards — the advisory groups that decide which drugs Medicaid will and won't cover. Gary Waters/Ikon Images/Getty Images hide caption
The deadline for signing up for individual health insurance coverage on HealthCare.gov ends Saturday, Dec. 15. Patrick Sison/AP hide caption